Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

v3.19.3.a.u2
Subsequent Events (Details Narrative) - Subsequent Events [Member] - USD ($)
Jan. 14, 2020
Jan. 10, 2020
Jan. 07, 2020
Maximum [Member]      
Exercise price     $ 4.00
Minimum [Member]      
Exercise price     $ 2.50
Chief Medical Officer [Member]      
Common stock purchased by the company 11,364    
Common stock price per share $ 4.79    
Total cost to the company $ 54,434    
Epigenetic Reagent Company Octamer GmbH [Member]      
Total purchase price of a company   $ 725,000  
Cash paid for purchases business   $ 400,000  
Restricted shares issued   73,263  
Former Director [Member]      
Issuance of common stock     17,483
Warrants exercised   60,000